Improving patient tolerance of mechanical ventilation. Challenges ahead

Area of Science:

• Critical Care Medicine
• Neuroscience
• Pharmacology

Background:

• Psychopharmacology and anesthesia practices in ICUs lag behind other medical settings.
• Unique patient characteristics in the ICU, such as organ dysfunction and prolonged treatment, necessitate distinct approaches.
• Existing knowledge from operating rooms cannot be directly translated to the ICU environment.

Purpose of the Study:

• To highlight the need for a specialized framework for psychotropic and neuromuscular blocking agents in the ICU.
• To emphasize the requirement for novel assessment tools for both research and clinical practice.
• To identify critical knowledge gaps in the use of these agents within the ICU.

Main Methods:

• Literature review and synthesis of current practices in ICU sedation and anesthesia.
• Analysis of pharmacokinetic and pharmacodynamic data relevant to critically ill patients.
• Identification of areas requiring further research and guideline development.

Main Results:

• Significant differences exist in applying operating room protocols to ICU settings.
• There is a lack of standardized assessment tools and clear indications for drug use.
• Insufficient data exists on drug pharmacokinetics, adverse effects, and cost-effectiveness in the ICU.

Conclusions:

• A novel conceptual framework is essential for guiding the use of sedating drugs and muscle relaxants in the ICU.
• Development of new assessment tools and practice guidelines is imperative.
• Addressing these needs will enhance the efficacy and safety of pharmacologic management, leading to a more humane ICU experience.